SCHEMBL14289690

SCHEMBL14289690

COC(=O)/C=C/c1ccc(C2=C(c3ccccc3)CCCc3ccccc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 11/20 0.48
ESR2 Q92731 2/20 0.45
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
TYR P14679 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
SLC6A3 Q01959 1/20 0.43
IP6K1 Q92551 1/20 0.40
IP6K3 Q96PC2 1/20 0.40
IP6K2 Q9UHH9 1/20 0.40
AKT1 P31749 1/20 0.40
AKT2 P31751 1/20 0.40
HDAC2 Q92769 1/20 0.39
MGLL Q99685 1/20 0.39
PTPN1 P18031 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6074943 0.93 ESR1 (0.47) ESR1ESR2CA12CA1CA2
SCHEMBL6074940 0.93 ESR1 (0.47) ESR1ESR2CA12CA1CA2
SCHEMBL5110186 0.87 ESR1 (0.57) ESR1ESR2HDAC2
SCHEMBL5110464 0.87 ESR1 (0.57) ESR1ESR2HDAC2
SCHEMBL14314213 0.85 CA12 (0.44) CA12CA1CA2TYRCA7
SCHEMBL14289689 0.85 CA12 (0.44) CA12CA1CA2TYRCA7
SCHEMBL6438798 0.85 ESR1 (0.47) ESR1ESR2AKT1AKT2HDAC2
SCHEMBL5117772 0.85 ESR1 (0.57) ESR1ESR2SLC6A3HDAC2
SCHEMBL5117765 0.85 ESR1 (0.57) ESR1ESR2SLC6A3HDAC2
SCHEMBL6437657 0.83 ESR1 (0.43) ESR1ESR2HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7323587-B2 Selective estrogen receptor modulators BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2008-01-29 US disclosed
US-7323587-B2 Selective estrogen receptor modulators BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2008-01-29 US disclosed